Torax Biosciences launches new ‘Best in Class’ Hand Sanitiser

Torax Biosciences, a leading Northern Ireland life sciences and biomedical company, has launched a revolutionary new, clinically approved hand sanitiser proven to kill 99.99% of bacteria and viruses.

By Claire Cartmill
Tuesday, 1st September 2020, 6:00 am
Pictured launching the ToraSan hand sanitiser range is Stephen Mullan, Torax Biosciences Laboratory Technician and Dr Lawrence McGrath PhD, MSc, T.D, Torax Biosciences Managing Director and esteemed clinical researcher
Pictured launching the ToraSan hand sanitiser range is Stephen Mullan, Torax Biosciences Laboratory Technician and Dr Lawrence McGrath PhD, MSc, T.D, Torax Biosciences Managing Director and esteemed clinical researcher

ToraSan is a locally produced sanitiser formulated and developed by scientists to meet internationally recognised quality standards.

Products are manufactured under strict laboratory conditions at the company’s Newtownabbey headquarters, led by Managing Director and esteemed clinical researcher and published scientific author, Dr Lawrence McGrath PhD, MSc, T.D.

Dr McGrath explained: “Since the beginning of the pandemic we have seen a host of companies adapt their business to provide essential sanitisers in response to the urgent requirement for supply, particularly for frontline and key workers.

Sign up to our daily newsletter

“As the threat persists, it is important that people continue to be vigilant and use a high-quality, clinically approved sanitiser capable of protecting everyone – from staff and customers to families and loved ones.

“ToraSan products are manufactured to the World Health Organisation’s recommended formulation with added Tea Tree Oil and are independently tested and verified to ensure the integrity of antibacterial and antiviral properties.”

ToraSan’s unique formula provides a minimum concentration of 75% isopropyl, certified by the World Health Organisation to provide the optimum level of protection against bacteria and viruses. Many hand sanitisers only provide between 60-70% alcohol concentration which can be incapable of killing viruses.

“ToraSan is formulated using isopropyl, which is the gold standard in antibacterial and antiviral defence. Not only does isopropyl provide optimal protection but it’s also kinder to skin. Ethanol-based sanitisers, whilst being potentially less effective, can also cause dry and cracked skin, or lead to more severe skin conditions with prolonged use. ToraSan also contains Tea Tree Oil, which helps protect the skin, providing its own well-known anti-inflammatory, antiseptic and antibacterial qualities”, continued Dr McGrath.

Available as an Instant Hand Sanitiser Spray in a range of volumes, from 50ml handbag bottles to 500ml desk bottles, the lightweight mist formula instantly dries on the hands without stickiness.

In addition, ToraSan is also available in 5 litre quantities in liquid and adapted gel for commercial use.

“Since we started developing this product we have been inundated with enquiries from distributors, pharmacies, retailers and commercial users. It is clear to us that consumers are becoming more educated in what products and formulations provide the optimum levels of protection and ToraSan offers the highest levels of protection on the market,” added Dr McGrath.

With a strong focus on research and development, the company is retaining all ToraSan profits to fund new scientific posts focused on research into the production of diagnostics for preeclampsia for use in developing countries where the condition can affect up to 16% of pregnancies [2] and is often fatal.

Established in 2014 and headquartered in Newtownabbey, Northern Ireland, Torax Biosciences is one of the fastest growing bioscience companies in the United Kingdom, exporting internationally to over 10 countries.

Torax Biosciences Ltd. designs, develops and manufactures in vitro diagnostic (IVD) reagents and novel quality controls for clinical laboratory use to inform the diagnosis of disease, guide clinical treatment and to mitigate or prevent future disease.

Last year, the company expanded its division of therapeutic areas to include infection prevention and control, providing a clinically approved hand sanitiser to the consumer market and incorporating a new e-commerce offering.

For more information visit

A message from the Editor:

Thank you for reading this story on our website. While I have your attention, I also have an important request to make of you.

In order for us to continue to provide high quality and trusted local news on this free-to-read site, I am asking you to also please purchase a copy of our newspaper whenever you are able to do so.

Our journalists are highly trained and our content is independently regulated by IPSO to some of the most rigorous standards in the world. But being your eyes and ears comes at a price. So we need your support more than ever to buy our newspapers during this crisis.

With the coronavirus lockdown having a major impact on many of our local valued advertisers - and consequently the advertising that we receive - we are more reliant than ever on you helping us to provide you with news and information by buying a copy of our newspaper when you can safely.

You can also enjoy unlimited access to the best news from across Northern Ireland and the UK by subscribing to

With a digital subscription, you can read more than five articles, see fewer ads, enjoy faster load times, and get access to exclusive newsletters and content. Visit now to sign up.

Thank you